APP and Alzheimer disease: The accumulation of Aβ deposition in the brain is the main pathological manifestation for the decline of cognitive function in neurodegenerative diseases such as DACD and AD, which is mainly composed of β-secretase and γ-secretase through sequential cleavage of APP, resulting in different Aβ42 and Aβ40 products, respectively.